Sleep Apnea Treatment Without CPAP: Options, Evidence & Candidacy
There are evidence-based alternatives to CPAP for some adults with obstructive sleep apnea, but severity alone cannot tell you which one fits. Treatment depends on the confirmed diagnosis, anatomy, body weight, positional pattern, comorbidities, PAP experience, dental status, surgical risk, insurance rules, and personal preferences.
Yes, some people with OSA can be treated without CPAP. Options include custom oral appliances, positional therapy for position-dependent OSA, weight-focused treatment when obesity contributes, selected upper-airway surgery, hypoglossal nerve stimulation, and some adjunctive therapies. But none should be chosen from “mild,” “moderate,” or “severe” OSA alone. CPAP/APAP remains a standard and highly effective treatment, especially when tolerated.
What Actually Determines Whether an Alternative Fits?
OSA should be established with appropriate sleep testing in clinical context. A wearable, snoring score or questionnaire alone is not enough.
AHI matters, but clinicians may also consider oxygen desaturation, symptoms, sleepiness and cardiovascular risk.
Jaw position, tonsils, nasal obstruction, tongue-base collapse and palate collapse can change which mechanical or surgical approaches are plausible.
Some people have OSA mainly while supine. Positional therapy is relevant only when the sleep study shows that pattern.
Obesity can contribute substantially to OSA and may open weight-management, medication, or bariatric-surgery pathways.
Heart failure, central apnea, lung disease, neuromuscular disease, pregnancy, medications and dental/TMJ issues can change candidacy and safety.
Mask fit, pressure intolerance, nasal symptoms and adherence barriers should be addressed before assuming PAP has “failed.”
Travel, comfort, reversibility, willingness to have surgery, dental tolerance and treatment burden all matter.
Insurance and Medicare criteria may be narrower than FDA labeling or professional-society guidance. Prior authorization is common.
Options-by-Evidence and Candidacy Matrix
| Option | Evidence / guideline role | Who may be considered | Key limits / contraindication context | Follow-up |
|---|---|---|---|---|
| Custom oral appliance | AASM/AADSM guideline-supported alternative | Adults with OSA who are CPAP-intolerant or prefer alternate therapy; anatomy/dentition must be suitable | TMJ/dental issues, occlusal changes, less average AHI reduction than CPAP | Qualified dentist oversight + repeat sleep testing |
| Positional therapy | Useful for confirmed positional OSA | People whose events are substantially worse when supine | Not a general substitute for non-positional OSA; long-term adherence varies | Confirm response, often with repeat testing/device data |
| Weight-focused treatment | Important when overweight/obesity contributes | Adults with obesity or excess weight as part of the OSA phenotype | Weight loss may improve but not eliminate OSA; treatment choice depends on comorbidity and medication/surgical candidacy | Repeat OSA assessment after clinically significant weight change |
| Tirzepatide | FDA-approved for moderate-to-severe OSA in adults with obesity | Adults with obesity and moderate-to-severe OSA who meet prescribing criteria | Prescription drug with contraindications, adverse effects and cost/coverage considerations; not for OSA without the approved obesity context | Prescriber monitoring + reassessment of OSA |
| Hypoglossal nerve stimulation | Implantable therapy for a selected subgroup | FDA-labeled moderate-to-severe OSA with PAP failure/intolerance and appropriate airway anatomy | Requires surgery; complete concentric palatal collapse is a contraindicating anatomic finding; central/mixed apnea burden and other criteria matter | Programming, clinical follow-up and sleep testing |
| Upper-airway / jaw surgery | AASM supports discussion of surgical referral in selected PAP-intolerant adults | People with surgically addressable anatomy, PAP intolerance, or selected pressure-related PAP problems | Procedure choice cannot be made from AHI alone; anatomy, BMI, operative risk and goals matter | Postoperative reassessment and repeat sleep testing |
| Myofunctional therapy | Evidence suggests benefit mainly as an adjunct in selected patients | Some adults willing to do structured exercises, often alongside another therapy | Effect is variable; should not be sold as a replacement for effective primary therapy in higher-risk disease | Symptom + objective reassessment when used for OSA |
| Nasal EPAP | Selected non-PAP device option with more limited evidence | Some adults with appropriate OSA characteristics, often when standard options are unsuitable or for selected use cases | Variable response; nasal obstruction and disease severity/context matter | Objective confirmation that it works for the individual |
Non-CPAP Options in More Detail
Custom Mandibular Advancement / Oral Appliance Therapy
AASM/AADSM guidance recommends that sleep physicians consider oral appliances for adults with OSA who are intolerant of CPAP or prefer alternate therapy. A qualified dentist should generally use a custom, titratable device, monitor dental/occlusal effects, and coordinate follow-up with the sleep clinician.
No powered machine during sleep; portable; useful in appropriately selected adults.
CPAP generally lowers AHI and improves oxygen measures more strongly on average.
Follow-up sleep testing to confirm efficacy; OTC mouthpieces are not equivalent to clinician-managed custom appliances.
Positional Therapy
Positional therapy is most relevant when a sleep study shows substantially more obstructive events while sleeping on the back. Side-sleeping strategies or vibrotactile devices may reduce AHI in that subgroup.
Clearly documented supine-dependent OSA.
May under-treat non-positional OSA or disease that remains clinically important off the back.
Weight-Focused Treatment
Weight reduction can improve OSA when excess weight contributes to airway collapse, but the response varies and residual OSA can remain. Lifestyle treatment, anti-obesity medication, and bariatric-surgery referral are different interventions with different eligibility and risks.
Requires individual prescribing assessment, adverse-effect review and contraindication screening.
AASM recommends discussing bariatric-surgery referral in selected PAP-intolerant adults with OSA and BMI ≥35 kg/m².
OSA severity can change after substantial weight loss; treatment should be reassessed rather than assumed cured.
Hypoglossal Nerve Stimulation (Inspire-Type Therapy)
Hypoglossal nerve stimulation is an implantable treatment for a selected subgroup of people with moderate-to-severe OSA who cannot use or tolerate PAP and meet anatomic and other candidacy criteria.
FDA labeling for Inspire was expanded to an AHI range up to 100 and a BMI warning up to 40. The label still requires PAP failure/intolerance and absence of complete concentric collapse at the soft palate. Central/mixed apnea burden and other contraindications also matter.
DISE/anatomic assessment and broader clinical criteria determine candidacy.
Implant procedure, device programming, future procedures/battery considerations and MRI/device compatibility must be reviewed.
Insurance criteria can differ from FDA labeling, so approval is not guaranteed from eligibility alone.
Upper-Airway and Jaw Surgery
AASM guidance focuses on when to discuss surgical referral, not on picking a procedure from an online chart. For adults who are intolerant or unaccepting of PAP and have BMI under 40, clinicians should discuss referral to a sleep surgeon as part of a patient-centered alternatives conversation. Specific procedures require detailed anatomic assessment and informed discussion of risks and benefits.
Examples include palatal procedures, tonsil surgery in selected anatomy, maxillomandibular advancement and other targeted operations.
Effectiveness and risk vary widely by procedure, anatomy and patient selection.
A surgical referral recommendation is not the same as a recommendation to undergo surgery.
Myofunctional / Oropharyngeal Exercise Therapy
Structured tongue and oropharyngeal exercises may improve AHI, snoring and some symptoms in selected adults. The evidence base is smaller and more heterogeneous than for PAP or oral appliances, so this is better described as a possible adjunct rather than a universal replacement.
Nasal Expiratory Positive Airway Pressure (EPAP)
Nasal EPAP uses small valves that create resistance during exhalation. Some studies show AHI reduction in selected patients, but response is variable. Nasal obstruction, disease pattern and severity can affect suitability, so efficacy should be confirmed objectively rather than assumed.
BiPAP and ASV Are Not “CPAP-Free” Treatments
Bi-level PAP and adaptive servo-ventilation are still forms of positive airway pressure therapy. They belong in a different clinical decision pathway rather than a list of machine-free alternatives.
May be used in selected patients for pressure intolerance, hypoventilation or other clinical reasons. It is not automatically “better” than CPAP for routine OSA.
Primarily relates to selected central or complex sleep-disordered breathing. It has important heart-failure safety considerations and should never be selected from an OSA webpage alone.
What Good Follow-Up Looks Like
Know what was measured: AHI, oxygenation, positional dependence, symptoms and relevant comorbidities.
Review anatomy, dental status, obesity, PAP barriers, central-apnea burden, surgical risk, medications and patient preferences.
Mask fit, pressure settings, humidification, nasal obstruction and coaching may turn an intolerable treatment into a workable one.
Symptoms alone are not enough. Oral appliances, surgery, positional devices and other therapies may need repeat PSG or HSAT depending on clinical context.
Clinically significant weight change, new cardiovascular disease, new medications or recurring symptoms can change OSA severity and treatment needs.
Screening and Symptom Guides
STOP-BANG screening only; not a diagnosis or treatment selector.
Evidence-ranked primary-snoring options and signs that should prompt OSA evaluation.
Position-specific guidance, including when non-supine sleep may help positional OSA.
Sleep Apnea Treatment Without CPAP FAQs
What is the best alternative to CPAP?
There is no single best alternative. The answer depends on confirmed OSA, anatomy, positional pattern, obesity, comorbidities, dental status, PAP tolerance, surgical risk, insurance rules and preference.
Can mild OSA always be treated with an oral appliance or positional therapy?
No. Severity alone does not establish candidacy. Oral appliances require appropriate dental/anatomic assessment, and positional therapy only makes sense when OSA is actually position-dependent.
Is Inspire better than CPAP?
It should not be framed as universally better. Hypoglossal nerve stimulation can work well in carefully selected PAP-intolerant patients, but it is an implant with strict candidacy requirements. CPAP remains more broadly applicable and highly effective when tolerated.
Is there now a medication approved for sleep apnea?
Yes. The FDA approved tirzepatide (Zepbound) for moderate-to-severe OSA in adults with obesity, used with a reduced-calorie diet and increased physical activity. It is not a general medication for every person with OSA.
Can surgery replace CPAP?
For some carefully selected people, surgery can substantially improve OSA. But procedure choice depends on anatomy, BMI, goals and surgical risk. AASM guidance recommends discussion of surgical referral in selected situations rather than choosing a procedure from severity alone.
Are BiPAP and ASV alternatives to CPAP?
They are alternatives to standard CPAP in some clinical situations, but they are still PAP therapies—not CPAP-free treatment. ASV is mainly relevant to selected central/complex breathing disorders and has important heart-failure safety restrictions.
Do I need another sleep study after starting an alternative?
Often, objective follow-up testing is important to confirm that treatment is controlling OSA. The appropriate test and timing depend on the therapy and clinical situation.
Sources
- AASM/AADSM. Clinical Practice Guideline for Oral Appliance Therapy for OSA and Snoring. AASM
- AASM. Referral of Adults With OSA for Surgical Consultation: Clinical Practice Guideline. AASM
- AASM. Positive Airway Pressure Treatment for Adult OSA. AASM
- FDA. Inspire Upper Airway Stimulation — expanded indications and labeling. FDA
- FDA. Approval of Zepbound (tirzepatide) for moderate-to-severe OSA in adults with obesity. FDA
- AASM. ASV safety notice for central sleep apnea in symptomatic heart failure with reduced LVEF. AASM
- AASM. Obesity-management resources and longitudinal OSA reassessment context. AASM
